Department of Surgery, Loyola University Medical Center, Maywood, IL; Burn and Shock Trauma Research Institute, Loyola University Chicago, Maywood, IL.
Burn and Shock Trauma Research Institute, Loyola University Chicago, Maywood, IL; Center for Health Outcomes and Informatics Research, Health Sciences Division, Loyola University Chicago, Maywood, IL; Department of Health Informatics and Data Science, Loyola University Chicago, Chicago, IL.
Surgery. 2021 Mar;169(3):636-643. doi: 10.1016/j.surg.2020.07.059. Epub 2020 Sep 18.
Few studies evaluate the impact of unhealthy alcohol and drug use on the risk and severity of postoperative outcomes after upper gastrointestinal and pancreatic oncologic resections.
The National Inpatient Sample was queried to identify patients undergoing total gastrectomy, esophagectomy, total pancreatectomy, and pancreaticoduodenectomy between 2012 and 2015. Unhealthy alcohol and drug use was assessed by the International Classification of Diseases, Ninth Revision, and National Inpatient Sample coder designation. Multivariable regression was used to identify associations between alcohol and drug use and postoperative complication, duration of stay, hospital cost, and mortality.
In the study, 59,490 patients met inclusion criteria; 2,060 (3.5%) had unhealthy alcohol use; 1,265 (2.1%) had unhealthy drug use. Postoperative complication rates were higher in patients with alcohol and drug use than in abstainers (67.5% vs 62.8% vs 57.2%; P < .01). On multivariable regression, alcohol use was independently associated with increased risk of a nonwithdrawal complication (odds ratio 1.33 [1.05, 1.68]), and alcohol and drug use were independently associated with increased length of stay (1.54 [0.12, 2.96]) and 2.22 [0.90, 3.55] days) and cost ($5,471 [$60, $10,881] and $4,022 [$402, $7,643]), but not mortality.
Unhealthy substance use is associated with increased rates of postoperative complications, prolonged length of stay, and costs in patients undergoing major upper gastrointestinal and pancreatic oncologic resections. Screening and abstinence interventions should be incorporated into the preoperative care pathways for these patients.
很少有研究评估不健康的酒精和药物使用对胃上消化道和胰腺肿瘤切除术后手术结果的风险和严重程度的影响。
利用国家住院患者样本,于 2012 年至 2015 年期间,确定接受全胃切除术、食管切除术、全胰切除术和胰十二指肠切除术的患者。使用国际疾病分类,第九版和国家住院患者样本编码来评估酒精和药物的使用情况。采用多变量回归来确定酒精和药物使用与术后并发症、住院时间、住院费用和死亡率之间的关系。
在这项研究中,共有 59490 名患者符合纳入标准;2060 名(3.5%)有不健康的酒精使用;1265 名(2.1%)有不健康的药物使用。有酒精和药物使用的患者术后并发症发生率高于戒酒者(67.5%比 62.8%比 57.2%;P <.01)。在多变量回归中,酒精使用与非戒断并发症的风险增加独立相关(比值比 1.33[1.05,1.68]),酒精和药物使用与住院时间延长(1.54[0.12,2.96])和 2.22[0.90,3.55]天)和费用($5471 [$60,$10881]和$4022 [$402,$7643])独立相关,但与死亡率无关。
不健康的物质使用与接受主要上消化道和胰腺肿瘤切除术的患者术后并发症发生率增加、住院时间延长和费用增加相关。这些患者的术前护理路径应纳入筛查和戒断干预措施。